Resources from the same session
2488 - Mutation tracking in circulating tumor DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype.
Presenter: Noelia Tarazona Llavero
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
5561 - FOxTROT: an international randomised controlled trial in 1053 patients evaluating neoadjuvant chemotherapy (NAC) for colon cancer.
Presenter: Dion Morton
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
5478 - Analysis of circulating tumor DNA (ctDNA) from patients enrolled in the IDEA-FRANCE phase III trial: prognostic and predictive value for adjuvant treatment duration
Presenter: Julien Taieb
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
4839 - Bevacizumab plus chemotherapy versus chemotherapy alone as first-line treatment for patients with RAS mutant unresectable colorectal liver-limited metastases- A single center randomized control trial
Presenter: Jianmin Xu
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Gastrointestinal tumours, colorectal - Invited Discussant LBA30_PR and 522O
Presenter: Clara Montagut Viladot
Session: Proffered Paper 1 – Gastrointestinal tumours, colorectal
Resources:
Slides